Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

18

Number of overlapping holdings

20.2%

% of WDNA's 91 holdings also in ARKG

48.6%

% of ARKG's 39 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus ARKG)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in ARKG
Overlap
TWIST BIOSCIENCE CORP. 3.4% 6.1% 3.4%
CRISPR THERAPEUTICS AG 1.8% 7.3% 1.8%
ALCOBRA LTD 1.7% 3.5% 1.7%
BEAM THERAPEUTICS, INC. 1.4% 3.9% 1.4%
VERTEX PHARMACEUTICALS INC 1.3% 2.7% 1.3%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to ARKG
IOVANCE BIOTHERAPEUTICS INC 3.9%
FATE THERAPEUTICS INC 3.1%
NOVOZYMES A/S-B SHARES 2.4%
BLUEPRINT MEDICINES CORP. 2.2%
BRIDGEBIO PHARMA, INC. 2.0%
ELI LILLY & CO 1.9%
VERICEL CORPORATION 1.7%
AGIOS PHARMACEUTICALS INC 1.6%
CARIBOU BIOSCIENCES, INC. 1.6%
EDITAS MEDICINE, INC. 1.6%
WDNA Underweight Relative to ARKG
CRISPR THERAPEUTICS AG -5.5%
RECURSION PHARMACEUTICALS, INC CLASS -5.2%
EXACT SCIENCES CORP -4.4%
ACCOLADE, INC. -4.0%
CAREDX, INC. -3.7%
SCHRODINGER, INC. -3.7%
TELADOC INC -3.4%
IONIS PHARMACEUTICALS, INC. -3.1%
INTELLIA THERAPEUTICS, INC. -3.0%
VEEVA SYSTEMS INC-CLASS A -2.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY